Skip to main content
David Holland, MD, Infectious Disease, Atlanta, GA, Grady Health System

DavidPrestonHollandMD

Infectious Disease Atlanta, GA

Associate Professor, Medicine, Emory University

Dr. Holland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Holland's full profile

Already have an account?

Clinical Expertise

  • Tuberculosis, HIV/AIDS, Public health, Latent Tuberculosis

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Infectious Disease, 2007 - 2009
  • Duke University
    Duke UniversityMHS, 2006 - 2009
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 1995 - 2001
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1995
  • Millsaps College
    Millsaps CollegeBS, Honors in Mathematics, Summa Cum Laude, 1987 - 1991

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1996 - 2025
  • NC State Medical License
    NC State Medical License 2006 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Barton F. Haynes Early Career Research Award 2009
  • Phi Beta Kappa 1991
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Treatment for Preventing Tuberculosis in Children and Adolescents: A Randomized Clinical Trial of a 3-month, 12-dose Regimen of a Combination of Rifapentine and Isoniazid  
    Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and A..., JAMA Pediatr, 1/1/2015
  • Three Months of Weekly Rifapentine plus Isoniazid Is Less Hepatotoxic than Nine Months of Daily Isoniazid for LTBI  
    Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium, Int J Tuberc Lung Dis, 1/1/2015
  • Public health costs for tuberculosis suspects in Wake County, North Carolina, United States  
    Park PH, Holland DP, Wade A, Goswami ND, Bissette D, Stout JE, Int J Tuberc Lung Dis, 1/1/2013
  • Join now to see all

Abstracts/Posters

  • Mycobacteriology Diagnostic Costs in an Inner-City Public Hospital: Are We Ready to Adopt the Xpert(R) MTB/RIF in Lieu of the Acid-Fast Bacilli (AFB) Smear?
    Schechter MC,* Snoeyenbos G, Wang YF, Holland DP, and Ray SR, ID Week, San Diego, CA, 1/1/2015
  • Does the Use of Key Terjms in Radiologic Interpretation Influence Treatment Initiation?
    Zeringue EN,* Allen MG, Luffman J, Fortenberry E Herrin KB, Stout JE, Holland DP, National TB Controllers Association, Atlanta, GA, 1/1/2014
  • 3HP in the Real World – The North Carolina Experience
    Zeringue EN,* Allen MG, Luffman J, Fortenberry E Herrin KB, Stout JE, Holland DP, National TB Controllers Association, Atlanta, GA, 1/1/2014
  • Join now to see all

Lectures

  • Appropriate Drug Regimens for MDR-TB Patients and Contacts 
    North Carolina Tuberculosis/Respiratory Diseases Institute - 1/1/2015
  • Treating Tuberculosis: Two Steps Forward, One Step Back 
    Emory University, Atlanta, GA - 1/1/2014
  • Using Imperfect Tests for the Diagnosis of LTBI 
    Atlanta, GA - 1/1/2014
  • Join now to see all

Other

  • Getting PrePared: Questions and Answers about a New Method of HIV Prevention 
    Holland DP, The Triangle: LGBTQ resource for the Raleigh, Durham and Chapel Hill area
    1/1/2012
  • North Carolina Guidelines for the Use of Interferon Gamma Release Assays (IGRAS) in Tuberculosis Diagnosis 
    Stout JE, Hendershot E, Holland DP, Ahmed A, Allen M, Fortenberry ER, Luffman J, Zeringue E, Herrin K, O’Rourke M, Ewing A, Ohl C, Cook P, Frothingham R, Hamilton CD, ..., NC Tuberculosis Control Website
    1/1/2009
  • Nucleic Acid Amplification Testing (NAA) For Tuberculosis: North Carolina State Laboratory of Public Health Testing and General Guidelines for Interpretation 
    Holland DP, NC Tuberculosis Control Manual

Press Mentions

  • Molecular HIV Cluster Detection Shines a Light on Priority Populations: Here’s How
    Molecular HIV Cluster Detection Shines a Light on Priority Populations: Here’s HowNovember 30th, 2022
  • There’s a Morning-After Pill to Prevent Sexually Transmitted Infections
    There’s a Morning-After Pill to Prevent Sexually Transmitted InfectionsOctober 25th, 2022
  • The CDC Scientist Who Couldn’t Get Monkeypox Treatment
    The CDC Scientist Who Couldn’t Get Monkeypox TreatmentOctober 5th, 2022
  • Join now to see all

Grant Support

  • Mathematical Modeling In Clinical Trials Of Tuberculosis TherapeuticsNational Institute Of Allergy And Infectious Diseases2009–2011

Hospital Affiliations